Loading…

Noscapine and diltiazem augment taxol and radiation-induced S-phase arrest and clonogenic death of C6 glioma in vitro

Radiation therapy after surgical resection is the approved treatment of gliomas, and survival benefits are reported with taxane-based chemotherapy. We investigated whether these regimes could be augmented with blood-brain barrier permeable drugs, N and D. Noscapine is an opioid antitussive, which ac...

Full description

Saved in:
Bibliographic Details
Published in:Surgical neurology 2006-05, Vol.65 (5), p.478-484
Main Authors: Altinoz, Meric A., Bilir, Ayhan, Del Maestro, Rolando F., Tuna, Sevilcan, Ozcan, Emin, Gedikoglu, Gunduz
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Radiation therapy after surgical resection is the approved treatment of gliomas, and survival benefits are reported with taxane-based chemotherapy. We investigated whether these regimes could be augmented with blood-brain barrier permeable drugs, N and D. Noscapine is an opioid antitussive, which acts anti cancer via blocking microtubule dynamics. Diltiazem is a calcium channel–blocking cardiac antiarrythmic, which also blocks tumor growth and P-glycoprotein. Effects of N (11.1 μmol/L), D (11.1 μmol/L), and T (11.7 μmol/L) were monitored in C6 glioma cells via S phase, colony formation, and fine structure analysis. Taxol depleted S phase from 35.2% to 12.2%. Both N and D synergistically augmented T-mediated S-phase depletion, and they also effectively reduced colonies, which were more potent by N by 49%. Taxol reduced colonies by 98%, and there were almost no surviving colonies in copresence of T with either N or D. Colony reduction by radiotherapy was increased strongly by T and significantly by N. Taxol and radiation profoundly increased number of mitochondria. Both D and N suppressed this increase via myelinosis and autophagy. Noscapine and D should be further tested in animal models because of their potential and already-present clinical applicability.
ISSN:0090-3019
1879-3339
DOI:10.1016/j.surneu.2005.06.024